The U.S. Food and Drug Administration is spending more and more time reviewing reports of liver damage caused by drugs. It is with this backdrop that results from a new Cancer study on a milk thistle-derived ingredient show some promise for maintaining liver health in individuals taking certain chemotherapeutics.
Anaheim, CA—Six eager companies are waiting to find out if they have won this year’s NutrAward, an annual award that honors firms that have invested in “rigorous and measurable scientific studies to prove the efficacy of their proprietary ingredients or technologies.”
Martek Biosciences Corporation of Columbia, MD, will make its first venture into finished goods manufacturing with the purchase of Amerifit Brands. Martek, the maker of life’sDHA (an algae-based source of DHA), purchased Amerifit for $200 million in cash ($80 million in loans, $120 million from cash reserves).
Sunrise, FL—In mid-December, an article published in The New York Times indicated that fish oil supplements are part of the reason for the depleting supplies of menhaden, a type of herring “upon which the entire Atlantic coastal ecosystem relies.” Originates, a fish oil concentrate supplier based here, put out a statement to address this misinformation, which Leslie van der Meulen, director of sales, stated could discourage shoppers from taking fish oil.
Industry now has additional data on one of the hottest nutrients on the market today: resveratrol. This ingredient, found in grapes and Japanese knotweed, is said to be responsible for the French paradox and various antioxidant benefits.
Hoboken, NJ—Diabetics know all too well that the disease affects more than just blood sugar. As many as 80% of those who have had diabetes for at least a decade will develop diabetic retinopathy, a condition that could lead to vision loss.